For example, glioma cells overexpressing oncogenic EGFRvIII, a constitutively active deletion mutant of the ligand-binding domain, drive the release of pathogenic EV subsets that carry increased oncogenic EGFR and invasiveness-related proteases and adhesion proteins (55) (Table 3). Here, EGFR is linked to glioma.